Literature DB >> 28964463

Managing Adverse Reactions to Contrast Agents.

Brian Boyd1, Carlos A Zamora2, Mauricio Castillo3.   

Abstract

Adverse reactions to iodinated and gadolinium-based contrast agents occur at an incidence of less than 1%. Although the exact pathophysiologic mechanisms are not completely understood, the treatment regimens are well accepted. Skin testing may be helpful in patients with a history of severe allergiclike reaction to aid in the selection of alternative contrast agents. Premedication should only be used for a history of allergiclike reaction. Imaging team members should be familiar with signs and symptoms of contrast reactions to allow for prompt assessment and treatment. A plan of action should be in place for contrast reactions and rehearsed regularly.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Adverse; Allergic; Anaphylactoid; Contrast; Gadolinium; Iodinated; Reaction

Mesh:

Substances:

Year:  2017        PMID: 28964463     DOI: 10.1016/j.mric.2017.06.008

Source DB:  PubMed          Journal:  Magn Reson Imaging Clin N Am        ISSN: 1064-9689            Impact factor:   2.266


  1 in total

1.  The contrast agent 2,3,5-triiodobenzoic acid (TIBA) induces cell death in tumor cells through the generation of reactive oxygen species.

Authors:  Jéssica Sodré Silva de Abreu; Janaína Fernandes
Journal:  Mol Biol Rep       Date:  2021-07-01       Impact factor: 2.316

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.